$4.47 Billion is the total value of Artal Group S.A.'s 148 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS INC | $342,368,000 | +4.8% | 71,178,364 | 0.0% | 7.66% | +15.5% | |
| WW | WW INTL INC | $270,434,000 | -49.5% | 14,818,300 | 0.0% | 6.05% | -44.3% | |
| BGNE | Sell | BEIGENE LTDsponsored adr | $235,950,000 | -19.1% | 650,000 | -23.5% | 5.28% | -10.8% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $212,292,000 | +54.6% | 1,200,000 | +41.2% | 4.75% | +70.4% |
| ARGX | Buy | ARGENX SEsponsored adr | $174,347,000 | +15.8% | 577,308 | +15.5% | 3.90% | +27.7% |
| XLRN | Sell | ACCELERON PHARMA INC | $172,100,000 | -2.0% | 1,000,000 | -28.6% | 3.85% | +8.0% |
| SEER | Sell | SEER INC | $164,018,000 | -10.5% | 4,750,000 | -15.0% | 3.67% | -1.3% |
| C | Sell | CITIGROUP INCcall | $140,360,000 | -27.9% | 2,000,000 | -27.3% | 3.14% | -20.5% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $132,167,000 | +4.0% | 700,000 | -6.7% | 2.96% | +14.6% |
| FCX | Buy | FREEPORT-MCMORAN INCcall | $113,855,000 | +309.1% | 3,500,000 | +366.7% | 2.55% | +350.8% |
| MORF | Sell | MORPHIC HLDG INC | $89,777,000 | -14.0% | 1,585,049 | -12.9% | 2.01% | -5.2% |
| IGMS | Buy | IGM BIOSCIENCES INC | $88,776,000 | -3.0% | 1,350,000 | +22.7% | 1.99% | +6.9% |
| FATE | Buy | FATE THERAPEUTICS INC | $85,942,000 | -26.6% | 1,450,000 | +7.4% | 1.92% | -19.1% |
| RUBY | Sell | RUBIUS THERAPEUTICS INC | $74,303,000 | -34.3% | 4,155,625 | -10.3% | 1.66% | -27.6% |
| GBIO | GENERATION BIO CO | $70,552,000 | -6.8% | 2,814,191 | 0.0% | 1.58% | +2.8% | |
| New | ERASCA INC | $67,315,000 | – | 3,172,221 | +100.0% | 1.51% | – | |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $64,389,000 | +11.4% | 1,950,000 | -2.5% | 1.44% | +22.8% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $63,956,000 | +76.9% | 6,696,955 | +78.6% | 1.43% | +95.0% |
| SGEN | New | SEAGEN INC | $63,675,000 | – | 375,000 | +100.0% | 1.42% | – |
| IMAB | Buy | I MABsponsored ads | $59,804,000 | -5.0% | 825,000 | +10.0% | 1.34% | +4.7% |
| BMY | BRISTOL-MYERS SQUIBB COcall | $59,170,000 | -11.4% | 1,000,000 | 0.0% | 1.32% | -2.4% | |
| ALVR | ALLOVIR INC | $58,224,000 | +27.0% | 2,323,371 | 0.0% | 1.30% | +40.0% | |
| CERE | Sell | CEREVEL THERAPEUTICS HLDNG I | $53,100,000 | +3.6% | 1,800,000 | -10.0% | 1.19% | +14.2% |
| CYTK | Buy | CYTOKINETICS INC | $46,462,000 | +369.6% | 1,300,000 | +160.0% | 1.04% | +417.4% |
| SAGE | SAGE THERAPEUTICS INC | $44,310,000 | -22.0% | 1,000,000 | 0.0% | 0.99% | -14.1% | |
| New | OMEGA THERAPEUTICS INC | $42,856,000 | – | 2,273,530 | +100.0% | 0.96% | – | |
| SDGR | Sell | SCHRODINGER INC | $38,276,000 | -36.5% | 700,000 | -12.2% | 0.86% | -30.1% |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $38,064,000 | -7.6% | 600,000 | +20.0% | 0.85% | +1.9% |
| MRK | New | MERCK & CO INCcall | $37,555,000 | – | 500,000 | +100.0% | 0.84% | – |
| ALXO | ALX ONCOLOGY HLDGS INC | $36,930,000 | +35.1% | 500,000 | 0.0% | 0.83% | +48.8% | |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $36,891,000 | -8.9% | 275,000 | +10.0% | 0.82% | +0.4% |
| VRTX | New | VERTEX PHARMACEUTICALS INCcall | $36,278,000 | – | 200,000 | +100.0% | 0.81% | – |
| BLU | Buy | BELLUS HEALTH INC NEW | $32,235,000 | +118.2% | 5,250,000 | +10.5% | 0.72% | +140.3% |
| GOSS | GOSSAMER BIO INC | $29,652,000 | +54.8% | 2,358,968 | 0.0% | 0.66% | +70.4% | |
| AGEN | Sell | AGENUS INC | $28,875,000 | -12.3% | 5,500,000 | -8.3% | 0.65% | -3.4% |
| TALS | TALARIS THERAPEUTICS INC | $27,991,000 | -7.7% | 2,064,262 | 0.0% | 0.63% | +1.8% | |
| KRON | KRONOS BIO INC | $27,624,000 | -12.5% | 1,317,954 | 0.0% | 0.62% | -3.6% | |
| ATRA | ATARA BIOTHERAPEUTICS INC | $26,850,000 | +15.1% | 1,500,000 | 0.0% | 0.60% | +27.1% | |
| ITOS | ITEOS THERAPEUTICS INC | $26,839,000 | +5.3% | 994,047 | 0.0% | 0.60% | +16.2% | |
| REPL | REPLIMUNE GROUP INC | $26,676,000 | -22.9% | 900,000 | 0.0% | 0.60% | -15.0% | |
| TGTX | TG THERAPEUTICS INC | $26,624,000 | -14.2% | 800,000 | 0.0% | 0.60% | -5.4% | |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $26,580,000 | – | 1,500,000 | +100.0% | 0.60% | – |
| KRYS | KRYSTAL BIOTECH INC | $26,105,000 | -23.2% | 500,000 | 0.0% | 0.58% | -15.4% | |
| DNLI | DENALI THERAPEUTICS INC | $25,225,000 | -35.7% | 500,000 | 0.0% | 0.56% | -29.1% | |
| FHTX | FOGHORN THERAPEUTICS INC | $23,970,000 | +30.6% | 1,720,720 | 0.0% | 0.54% | +43.7% | |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $23,496,000 | +93.8% | 400,000 | +60.0% | 0.53% | +113.8% |
| TPTX | TURNING POINT THERAPEUTICS I | $23,251,000 | -14.9% | 350,000 | 0.0% | 0.52% | -6.1% | |
| FMTX | FORMA THERAPEUTICS HLDGS INC | $23,190,000 | -6.8% | 1,000,000 | 0.0% | 0.52% | +2.8% | |
| SQZ | SQZ BIOTECHNOLOGIES CO | $23,163,000 | -0.2% | 1,606,309 | 0.0% | 0.52% | +10.0% | |
| OTLY | OATLY GROUP ABsponsored ads | $22,680,000 | -38.2% | 1,500,000 | 0.0% | 0.51% | -31.9% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $22,188,000 | +1.1% | 1,200,000 | 0.0% | 0.50% | +11.5% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $22,130,000 | +70.8% | 1,000,000 | 0.0% | 0.50% | +88.2% | |
| KURA | Buy | KURA ONCOLOGY INC | $19,667,000 | +57.2% | 1,050,000 | +75.0% | 0.44% | +73.2% |
| IKNA | IKENA ONCOLOGY INC | $19,555,000 | -10.1% | 1,549,513 | 0.0% | 0.44% | -0.9% | |
| TSHA | TAYSHA GENE THERAPIES INC | $19,381,000 | -12.2% | 1,040,882 | 0.0% | 0.43% | -3.1% | |
| VERV | Sell | VERVE THERAPEUTICS INC | $18,800,000 | -37.6% | 400,000 | -20.0% | 0.42% | -31.1% |
| ALBO | ALBIREO PHARMA INC | $18,720,000 | -11.3% | 600,000 | 0.0% | 0.42% | -2.1% | |
| NEXI | NEXIMMUNE INC | $18,168,000 | -7.2% | 1,200,000 | 0.0% | 0.41% | +2.3% | |
| NG | NOVAGOLD RES INC | $17,888,000 | -14.1% | 2,600,000 | 0.0% | 0.40% | -5.4% | |
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $17,569,000 | -20.4% | 2,255,375 | 0.0% | 0.39% | -12.3% | |
| SELB | SELECTA BIOSCIENCES INC | $16,640,000 | -0.5% | 4,000,000 | 0.0% | 0.37% | +9.7% | |
| LPTX | Buy | LEAP THERAPEUTICS INC | $16,040,000 | +226.0% | 4,000,000 | +33.3% | 0.36% | +259.0% |
| INTC | Sell | INTEL CORPcall | $15,984,000 | -78.1% | 300,000 | -76.9% | 0.36% | -75.8% |
| BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $14,805,000 | – | 100,000 | +100.0% | 0.33% | – |
| RPTX | REPARE THERAPEUTICS INC | $14,432,000 | -15.8% | 550,000 | 0.0% | 0.32% | -7.2% | |
| ADAG | ADAGENE INCads | $14,365,000 | +5.9% | 1,000,000 | 0.0% | 0.32% | +16.7% | |
| APTX | APTINYX INC | $14,313,000 | -17.3% | 6,116,493 | 0.0% | 0.32% | -8.8% | |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $14,112,000 | -52.7% | 700,000 | -12.5% | 0.32% | -47.9% |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $13,930,000 | -30.6% | 1,646,517 | 0.0% | 0.31% | -23.3% | |
| ZYME | ZYMEWORKS INC | $13,068,000 | -16.3% | 450,000 | 0.0% | 0.29% | -7.9% | |
| RLAY | RELAY THERAPEUTICS INC | $12,612,000 | -13.8% | 400,000 | 0.0% | 0.28% | -5.1% | |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $11,718,000 | -30.1% | 250,000 | -9.1% | 0.26% | -22.9% |
| GRPH | GRAPHITE BIO INC | $11,473,000 | -46.7% | 700,000 | 0.0% | 0.26% | -41.2% | |
| AMAM | AMBRX BIOPHARMA INCsponsored ads | $11,475,000 | -31.1% | 850,000 | 0.0% | 0.26% | -24.0% | |
| MARINUS PHARMACEUTICALS INC | $11,380,000 | -36.6% | 1,000,000 | 0.0% | 0.26% | -29.9% | ||
| YMAB | Y-MABS THERAPEUTICS INC | $11,416,000 | -15.6% | 400,000 | 0.0% | 0.26% | -6.9% | |
| NBTX | NANOBIOTIX SAsponsored ads | $11,360,000 | -17.6% | 1,000,000 | 0.0% | 0.25% | -9.3% | |
| MRSN | MERSANA THERAPEUTICS INC | $11,316,000 | -30.6% | 1,200,000 | 0.0% | 0.25% | -23.6% | |
| LYEL | LYELL IMMUNOPHARMA INC | $10,360,000 | -8.9% | 700,000 | 0.0% | 0.23% | +0.4% | |
| BPMC | BLUEPRINT MEDICINES CORP | $10,281,000 | +16.9% | 100,000 | 0.0% | 0.23% | +28.5% | |
| CRIS | CURIS INC | $10,179,000 | -3.0% | 1,300,000 | 0.0% | 0.23% | +7.0% | |
| New | CARIBOU BIOSCIENCES INC | $9,676,000 | – | 405,347 | +100.0% | 0.22% | – | |
| SPRO | SPERO THERAPEUTICS INC | $9,205,000 | +31.9% | 500,000 | 0.0% | 0.21% | +45.1% | |
| SANA | SANA BIOTECHNOLOGY INC | $9,008,000 | +14.5% | 400,000 | 0.0% | 0.20% | +26.2% | |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $8,940,000 | -3.5% | 2,000,000 | +17.6% | 0.20% | +6.4% |
| VOR | VOR BIOPHARMA INC | $8,624,000 | -15.9% | 550,000 | 0.0% | 0.19% | -7.2% | |
| DYN | DYNE THERAPEUTICS INC | $8,526,000 | -22.8% | 525,000 | 0.0% | 0.19% | -14.7% | |
| CYCN | CYCLERION THERAPEUTICS INC | $8,532,000 | -21.3% | 2,779,122 | 0.0% | 0.19% | -13.2% | |
| OVID | OVID THERAPEUTICS INC | $8,400,000 | -14.1% | 2,500,000 | 0.0% | 0.19% | -5.1% | |
| ORIC | ORIC PHARMACEUTICALS INC | $8,364,000 | +18.2% | 400,000 | 0.0% | 0.19% | +29.9% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $8,308,000 | +14.2% | 1,045,000 | 0.0% | 0.19% | +25.7% | |
| TIL | INSTIL BIO INC | $8,044,000 | -7.5% | 450,000 | 0.0% | 0.18% | +2.3% | |
| IQ | IQIYI INCsponsored ads | $8,030,000 | -48.5% | 1,000,000 | 0.0% | 0.18% | -43.0% | |
| HARP | HARPOON THERAPEUTICS INC | $7,900,000 | -43.0% | 1,000,000 | 0.0% | 0.18% | -37.2% | |
| IMCR | IMMUNOCORE HLDGS PLCads | $7,414,000 | -5.1% | 200,000 | 0.0% | 0.17% | +4.4% | |
| OMEG | OMEGA ALPHA SPACcl a | $7,301,000 | -2.2% | 750,000 | 0.0% | 0.16% | +7.9% | |
| OLMA | OLEMA PHARMACEUTICALS INC | $7,179,000 | -1.5% | 260,500 | 0.0% | 0.16% | +8.8% | |
| SLDB | Buy | SOLID BIOSCIENCES INC | $7,170,000 | -12.9% | 3,000,000 | +33.3% | 0.16% | -4.2% |
| EVLO | EVELO BIOSCIENCES INC | $7,040,000 | -48.8% | 1,000,000 | 0.0% | 0.16% | -43.4% | |
| ACIU | AC IMMUNE SA | $6,710,000 | -15.4% | 1,000,000 | 0.0% | 0.15% | -6.8% | |
| APLT | APPLIED THERAPEUTICS INC | $6,640,000 | -20.1% | 400,000 | 0.0% | 0.15% | -11.8% | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $6,510,000 | -38.0% | 3,000,000 | 0.0% | 0.15% | -31.5% | |
| TCRR | TCR2 THERAPEUTICS INC | $6,383,000 | -48.1% | 750,000 | 0.0% | 0.14% | -42.8% | |
| ALPN | ALPINE IMMUNE SCIENCES INC | $6,328,000 | +18.6% | 593,030 | 0.0% | 0.14% | +31.5% | |
| STOK | STOKE THERAPEUTICS INC | $6,360,000 | -24.4% | 250,000 | 0.0% | 0.14% | -17.0% | |
| IMUX | IMMUNIC INC | $6,195,000 | -27.8% | 700,000 | 0.0% | 0.14% | -20.1% | |
| CFRX | CONTRAFECT CORP | $6,075,000 | -8.0% | 1,500,000 | 0.0% | 0.14% | +1.5% | |
| FUSN | FUSION PHARMACEUTICALS INC | $5,940,000 | -2.0% | 750,000 | 0.0% | 0.13% | +8.1% | |
| YI | 111 INCads | $5,962,000 | -32.1% | 966,349 | 0.0% | 0.13% | -25.3% | |
| DSGN | DESIGN THERAPEUTICS INC | $5,876,000 | -26.1% | 400,000 | 0.0% | 0.13% | -18.6% | |
| GDS | New | GDS HLDGS LTDsponsored ads | $5,661,000 | – | 100,000 | +100.0% | 0.13% | – |
| New | OLAPLEX HLDGS INC | $5,513,000 | – | 225,000 | +100.0% | 0.12% | – | |
| CRDF | CARDIFF ONCOLOGY INC | $4,995,000 | +0.1% | 750,000 | 0.0% | 0.11% | +10.9% | |
| DYNS | DYNAMICS SPECIAL PURPOSE COR | $4,970,000 | 0.0% | 500,000 | 0.0% | 0.11% | +9.9% | |
| WVE | New | WAVE LIFE SCIENCES LTD | $4,900,000 | – | 1,000,000 | +100.0% | 0.11% | – |
| ARAV | ARAVIVE INC | $4,878,000 | -37.8% | 1,311,291 | 0.0% | 0.11% | -31.4% | |
| RXRX | RECURSION PHARMACEUTICALS INcl a | $4,602,000 | -37.0% | 200,000 | 0.0% | 0.10% | -30.4% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $4,149,000 | -47.6% | 1,803,858 | 0.0% | 0.09% | -42.2% | |
| IMMP | IMMUTEP LTDsponsored ads | $3,870,000 | 0.0% | 1,000,000 | 0.0% | 0.09% | +10.1% | |
| New | PORTAGE FINTECH ACQUISITN CO | $3,800,000 | – | 380,000 | +100.0% | 0.08% | – | |
| MREO | MEREO BIOPHARMA GROUP PLCads | $3,630,000 | -23.7% | 1,500,000 | 0.0% | 0.08% | -16.5% | |
| RNA | AVIDITY BIOSCIENCES INC | $3,510,000 | -0.3% | 142,500 | 0.0% | 0.08% | +11.3% | |
| HOOK | HOOKIPA PHARMA INC | $3,532,000 | -35.7% | 599,616 | 0.0% | 0.08% | -28.8% | |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $3,398,000 | -53.6% | 100,000 | -50.0% | 0.08% | -49.0% |
| CDAK | CODIAK BIOSCIENCES INC | $3,266,000 | -11.9% | 200,000 | 0.0% | 0.07% | -2.7% | |
| MTCR | METACRINE INC | $3,172,000 | -9.8% | 924,898 | 0.0% | 0.07% | 0.0% | |
| KNTE | KINNATE BIOPHARMA INC | $2,878,000 | -1.1% | 125,000 | 0.0% | 0.06% | +8.5% | |
| New | HIPPO HLDGS INC | $2,808,000 | – | 600,000 | +100.0% | 0.06% | – | |
| MEIP | MEI PHARMA INC | $2,760,000 | -3.2% | 1,000,000 | 0.0% | 0.06% | +6.9% | |
| KLDO | KALEIDO BIOSCIENCES INC | $2,733,000 | -26.6% | 500,500 | 0.0% | 0.06% | -19.7% | |
| CRVS | New | CORVUS PHARMACEUTICALS INC | $2,420,000 | – | 500,000 | +100.0% | 0.05% | – |
| KDNY | CHINOOK THERAPEUTICS INC | $2,303,000 | -9.7% | 180,500 | 0.0% | 0.05% | 0.0% | |
| CGEM | CULLINAN ONCOLOGY INC | $2,257,000 | -12.3% | 100,000 | 0.0% | 0.05% | -3.8% | |
| YMTX | YUMANITY THERAPEUTICS INC | $2,243,000 | -11.4% | 217,391 | 0.0% | 0.05% | -2.0% | |
| AXLA | AXCELLA HEALTH INC | $2,123,000 | -25.7% | 712,500 | 0.0% | 0.05% | -17.2% | |
| AVTR | New | AVANTOR INC | $2,045,000 | – | 50,000 | +100.0% | 0.05% | – |
| AMYT | New | AMRYT PHARMA PLCsponsored ads | $1,813,000 | – | 150,480 | +100.0% | 0.04% | – |
| SGTX | SIGILON THERAPEUTICS INC | $1,559,000 | -47.3% | 276,000 | 0.0% | 0.04% | -41.7% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,444,000 | +1.5% | 110,532 | 0.0% | 0.03% | +10.3% | |
| LVTX | LAVA THERAPEUTICS NV | $1,184,000 | -45.6% | 200,000 | 0.0% | 0.03% | -40.9% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $1,166,000 | -16.4% | 321,100 | 0.0% | 0.03% | -7.1% | |
| SURF | SURFACE ONCOLOGY INC | $757,000 | +1.5% | 100,000 | 0.0% | 0.02% | +13.3% | |
| ATUS | New | ALTICE USA INCcl a | $559,000 | – | 27,000 | +100.0% | 0.01% | – |
| CDTX | CIDARA THERAPEUTICS INC | $503,000 | +10.8% | 224,675 | 0.0% | 0.01% | +22.2% | |
| New | ASTRIA THERAPEUTICS INC | $295,000 | – | 33,333 | +100.0% | 0.01% | – | |
| EQT | New | EQT CORP | $198,000 | – | 9,678 | +100.0% | 0.00% | – |
| LU | Exit | LUFAX HOLDING LTD | $0 | – | -50,000 | -100.0% | -0.01% | – |
| CEREW | Exit | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $0 | – | -79,600 | -100.0% | -0.02% | – |
| CHMA | Exit | CHIASMA INC | $0 | – | -380,000 | -100.0% | -0.04% | – |
| MOLN | Exit | MOLECULAR PARTNERS AGads | $0 | – | -100,000 | -100.0% | -0.04% | – |
| VIAC | Exit | VIACOMCBS INCcl b | $0 | – | -75,000 | -100.0% | -0.07% | – |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -0.10% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -431,894 | -100.0% | -0.10% | – |
| BHG | Exit | BRIGHT HEALTH GROUP INC | $0 | – | -305,555 | -100.0% | -0.11% | – |
| AGL | Exit | AGILON HEALTH INC | $0 | – | -300,000 | -100.0% | -0.25% | – |
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -500,000 | -100.0% | -0.28% | – |
| LFST | Exit | LIFESTANCE HEALTH GROUP INC | $0 | – | -500,000 | -100.0% | -0.28% | – |
| DLO | Exit | DLOCAL LTD | $0 | – | -295,000 | -100.0% | -0.32% | – |
| CAR | Exit | AVIS BUDGET GROUP | $0 | – | -300,000 | -100.0% | -0.47% | – |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -2,500,000 | -100.0% | -0.49% | – | |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -400,000 | -100.0% | -0.79% | – |
| F | Exit | FORD MTR CO DELcall | $0 | – | -3,500,000 | -100.0% | -1.06% | – |
| GM | Exit | GENERAL MTRS COcall | $0 | – | -2,000,000 | -100.0% | -2.40% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.